Journal of Clinical Oncology

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Journal of Clinical Oncology
Sep 15, 2024, 12:53 | Blog
Sumanta Pal's highlights from ESMO24
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 13, 2024, 15:01 | Insight
Piotr Wysocki: IPMN-derived pancreatic cancer patients benefit from adjuvant chemotherapy only with nodal involvement and elevated preoperative CA19-9
Piotr Wysocki recently shared a post on LinkedIn: "A recent international multicenter study published in…
Sep 12, 2024, 15:37 | Insight
Bertrand Tombal: Do Not EMBARK on When, If the Answer Is How
Bertrand Tombal, Chairman, Department of Surgery, Cliniques universitaires Saint-Luc, shared a post on X: "The…
Sep 11, 2024, 16:34 | Insight
Andrea Necchi: Our next piece of the neoadjuvant puzzle in muscle-invasive bladder cancer
Andrea Necchi, Associate Editor at Journal of Clinical Oncology, shared a post on X about…
Sep 11, 2024, 08:57 | Insight
TROPION-Lung01 Presents Further Data on Dato-DXd for NSCLC at WCLC - ASCO
American Society of Clinical Oncology (ASCO) shared a post on LinkedIn: "Lung Cancer Study (TROPION-Lung01)…
Sep 11, 2024, 06:09 | Blog
Vivek Subbiah: First-in human phase 1 dose-escalation study of BT5528 in Patients With Advanced Solid Tumors
Vivek Subbiah shared a post on X: "Hot of the press - Pleased to share our…
Sep 11, 2024, 01:59 | Societies
38 Posts Not to Miss From WCLC24 Day 3!
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Sep 10, 2024, 13:45 | Societies
Rami Manochakian's key highlights from WCLC24
WCLC is a major international event focused on the latest advancements in lung cancer research,…
Sep 8, 2024, 16:13 | Insight
Tomas G. Neilan: Can large language models outperform ICD codes in detecting severe immune-related adverse events?
Tomas G. Neilan, Director of the Cardio-Oncology Program at Massachusetts General Hospital, shared on X:…
Sep 7, 2024, 19:36 | Insight
A year of treatment with an ADC has proven highly effective in preventing stage 1 HER2-positive breast cancer from recurring - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared the following on LinkedIn: “A year of treatment with a medicine…
Sep 6, 2024, 12:30 | Career
Mikkael A. Sekeres, Candidate for Secretary of ASH
Mikkael A. Sekeres, Chair of Committee on Communications at American Society of Hematology (ASH) is…
Sep 4, 2024, 06:42 | Insight
Layth Mula-Hussain: Where does the MENAT region stand in radiation oncology
Layth Mula-Hussain shared on LinkedIn: “Delighted to be part of this recently ASCO JCO GO…
Sep 2, 2024, 03:14 | Insight
Othman Al-Sawaf: Surrogacy of endpoints in 1L CLL trials
Othman Al-Sawaf, Haematologist and Medical Oncologist at the University Hospital Cologne, Cologne, Germany, shared a…
Sep 1, 2024, 20:21 | Blog
Andrea Necchi: MRI should be a routine for daily management of MIBC
Andrea Necchi, Associate Editor at Journal of Clinical Oncology, shared Nick James's, Professor of Prostate…
Sep 1, 2024, 08:30 | Insight
Sacituzumab Govitecan in cisplatin-ineligible metastatic urothelial cancer after CPI
TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic…
Aug 31, 2024, 09:45 | Insight
Piotr Wysocki: Older patients with mCRC receiving fluoropyrimidine+bevacizumab do not gain additional benefit from adding oxaliplatin
Piotr Wysocki recently shared on LinkedIn: "A recent phase III clinical trial published in the…
Aug 25, 2024, 14:15 | Insight
JCO Study Confirms Annual Mammograms Improve Breast Cancer Outcomes Across All Demographics
American Society of Clinical Oncology (ASCO) shared a post on LinkedIn about a recent paper…
Aug 22, 2024, 20:35 | Insight
Oral Cannabis for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting
The final results of the study on Oral Cannabis Extract for the secondary prevention of…
Aug 22, 2024, 15:06 | Insight
Elias Karam: The ultimate dilemma of corticosteroids and Immunotherapy
Elias Karam, Hematology and Medical Oncology Fellow at Gustave Roussy, shared a post on LinkedIn about…
Aug 20, 2024, 16:41 | Insight
Elvina Almuradova: Metastasis-free or treatment-free survival
Elvina Almuradova, Medical Oncologist Ambassador at European School of Oncology, shared a post on X about…
Aug 19, 2024, 11:57 | Insight
Katsuaki Maehara: Interesting indirect comparison analysis for Melanoma
Katsuaki Maehara shared a post on X: "Melanoma Journal of Clinical Oncology. NCCN Guidelines recommended both…
Aug 19, 2024, 10:18 | Insight
Ryan Nipp: Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting
Ryan Nipp, Oncologist at University of Oklahoma, shared on X a recent article published in Journal…
Aug 18, 2024, 07:29 | Blog,Opinion
Paolo Tarantino: Do all patients with TNBC need 5 neoadjuvant drugs + 1 year of IO?
Paolo Tarantino shared a post on X about recent paper by Marleen Kok et al., titled…
Aug 14, 2024, 06:28 | Insight
Myriam Chalabi: Management of Locally Advanced Rectal Cancer: - ASCO Guideline
Myriam Chalabi shared on X: "Now online in the Journal of Clinical Oncology! Management of…
Aug 13, 2024, 18:32 | Blog
Nathan Pennell: Such an important statement to reduce administrative burden on research sites
Nathan Pennell, Professor and Vice Chair of Clinical Research at Cleveland Clinic, shared a post…
Aug 12, 2024, 21:46 | Blog
GI cancers - rapid oral abstracs in ASCOBT 24 summarized by Erman Akkus
Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared on X: "GI…
Aug 12, 2024, 20:58 | Insight
Post-transplant maintenance for AML: Review of literature by Talha Badar
Talha Badar shared a post on X: "Post transplant maintenance for AML. How should you…
Aug 12, 2024, 04:06 | Blog
Akihiro Ohba: Trastuzumab Deruxtecan in HER 2–Expressing Biliary Tract Cancer
Akihiro Ohba, Medical Oncologist at Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital,…
Aug 11, 2024, 12:56 | Insight
Trastuzumab Deruxtecan in HER2–Expressing BTC - Key points by Arndt Vogel
Arndt Vogel shared a post on X: "Trastuzumab Deruxtecan in HER2–Expressing BTC published in  Journal of…
Aug 11, 2024, 12:18 | Insight
Jordan Hansford: The importance of rigorous trials with "new" and novel agents
Jordan Hansford, McClurg Brain Cancer Fellow at SAHMRI, shared on X about a recent paper…
Aug 11, 2024, 11:59 | Blog
Myriam Chalabi: Management of Locally Advanced Rectal Cancer, ASCO Guidelines
Myriam Chalabi, Medical Oncologist at The Netherlands Cancer Institute, shared a post on X about…
Aug 11, 2024, 10:29 | Blog
The intratumoral microbiome in lung cancer
Sumanta K. Pal shared a post on X: "HUGE congrats to Arielle Elkrief, Smruthy Sivakumar, Marc…
Aug 10, 2024, 15:51 | Insight
Steroids for irAEs and ICI efficacy: analysis from 6 trials
Jarushka Naidoo shared a post on X about a recent paper by Karijn Suijkerbuijk et…
Aug 10, 2024, 12:57 | Insight
MD Anderson Research Highlights
Featuring cell biology insights, new targets to prevent dysphagia, improved treatments for advanced cancers and…
Aug 9, 2024, 02:19 | Blog
Activity of T-DXd in HER2-expressing Biliary Tract Cancer
Paolo Tarantino shared on X: "Activity of T-DXd in HER2-expressing BTC published in Journal of Clinical…
Aug 8, 2024, 12:35 | Blog
Miguel Bronchud: Liquid biopsy to detect early breast cancers
Miguel Bronchud, Co-Founder and Advisory Board at Regenerative Medicine Solutions, shared a post on LinkedIn,…
Aug 8, 2024, 01:43 | Insight
Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer - MD Anderson Cancer Center 
Approach achieves some of the longest progression-free survival times reported in a clinical trial for…
Aug 7, 2024, 16:01 | Insight
Piotr Wysocki: Trastuzumab Deruxtecan Shows Promise in Treating HER2-Positive Biliary Tract Cancer
Piotr Wysocki recently shared on LinkedIn: "A recent phase II clinical trial conducted across five…
Aug 6, 2024, 14:09 | Blog
DeepHRD predicts HRD from routine biopsy slides
Elvina Almuradova, Medical Oncologist Ambassador at European School of Oncology, shared a post on X,…
Aug 4, 2024, 23:39 | Insight
HERALD EPOC1806 study explores trastuzumab deruxtecan in solid tumors with HER2 amplification by ctDNA
Stephen Liu shared a post on X: "HERALD EPOC1806 study published in JCO explored trastuzumab…
Aug 2, 2024, 01:47 | Blog
Sergio Cifuentes Canaval: Neoadjuvant Chemo-Immuno for ER+ HER- breast cancer
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT Mexico, shared on LinkedIn about recent…
Jul 30, 2024, 06:39 | Insight
Ph II KUPENG trial of Vebreltinib in Advanced MetExon14 and NSCLC
Jarushka Naidoo shared a post on X about a recent paper by Jin-Ji Yang et…
Jul 30, 2024, 01:45 | Insight
TKIs with vs without upfront SRS for EGFR+ and ALK+ NSCLC and brain metastasis
Biagio Ricciuti shared on X about a recent paper by Luke Pike et al. titled…
Jul 27, 2024, 14:57 | Insight
Edward Cliff: The development and clinical trial design of T-cell lymphoma drugs pralatrexate and belinostat
Edward Cliff, Haematology Registrar at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, shared a…
Jul 27, 2024, 13:30 | Insight
Piotr Wysocki: Impact of genomic risk on response to extended adjuvant endocrine therapy
Piotr Wysocki recently posted on LinkedIn: "A recent study published in the Journal of Clinical Oncology…
Jul 25, 2024, 14:02 | Insight
Erman Akkus: Should up-front SRS be added to TKI in brain metastatic EGFR/ALK positive NSCLC?
Erman Akkus, Medical Oncologist at Ankara University, shared a paper by Luke R.G. Pike et al. on…
Jul 25, 2024, 08:58 | Insight
Marleen Kok: How do we get from one-size-fits-all to personalized treatment for TNBC
Marleen Kok, Breast Medical Oncologist at the Netherlands Cancer Institute, shared on X: "Today from…
Jul 22, 2024, 02:26 | Insight
New Chapter in Ewing Sarcoma Treatment - The story of TK216
Shushan Hovsepyan shared a post on LinkedIn about a recent paper by Paul Meyers et…
Jul 21, 2024, 15:37 | Insight
Neoadjuvant osimertinib for resectable EGFR NSCLC
Stephen V Liu shared on X a recent paper by Collin M. Blakely et al.…
Jul 21, 2024, 13:36 | Blog
Rami Manochakian: Neoadjuvant osimertinib in stage I-IIIA EGFRm NSCLC did not meet primary endpoint
Rami Manochakian shared a post on X: ''Hot off the press. Neoadjuvant Osimertinib for the…
Jul 20, 2024, 22:54 | Blog
David S. Miller: Why Cisplatin should not be added to radiotherapy for certain recurrent Endometrial Cancer
David Scott Miller, Gynaecologic Oncologist and Professor at Department of Obstetrics and Gynaecology at UT…
Jul 20, 2024, 12:53 | Insight
Cyclophosphamide–Based GVHD Prophylaxis Reduces Outcome Disparity in Transplants
CIBMTR shared a post on X about a recent paper.  . Authors: Brian C. Shaffer,…
Jul 19, 2024, 13:20 | Blog
Alexios Matikas: We show for the first time the superiority of dose dense versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer
Alexios Matikas, Associate Professor of Oncology at Karolinska Institute, shared on LinkedIn: "Dose dense is…
Jul 18, 2024, 10:41 | Insight
Systemic Therapy in Breast Cancer
Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared on X about…
Jul 17, 2024, 23:36 | Blog
Ishwaria Subbiah: Discussion on dissemination of evidence-based care of older adults with cancer with CARG
Ishwaria Subbiah shared on LinkedIn: "Superb discussion within our Cancer and Aging Research Group (CARG) core…
Jul 17, 2024, 21:52 | Blog
Ishwaria Subbiah: Superb discussion on dissemination of evidence-based care of older adults with cancer
Ishwaria Subbiah shared a post on X: ''Superb discussion within our Cancer and Aging Research…
Jul 16, 2024, 13:55 | Blog
5 papers to read suggested by Vivek Subbiah
We are presenting articles suggested by Vivek Subbiah: 1.'Pancreatic Cancer Surveillance and Survival of High-Risk…
Jul 13, 2024, 22:16 | Insight
Erman Akkus: Management of cancer-related fatigue - ASCO guideline
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X about a…
Jul 9, 2024, 07:25 | Insight
Piotr Wysocki: Checkpoint inhibitor and TKI combinations in GU malignancies
Piotr Wysocki recently posted on LinkedIn: "A phase I study (Apolo AB et al. J Clin…
Jul 8, 2024, 14:29 | Blog
Shahrin Ahmed: A new radiotherapy technique for treating head and neck cancer
Shahrin Ahmed, medical specialist at Canadian Cancer Society, shared on X: "A new radiotherapy technique…
Jul 6, 2024, 12:24 | Career
Omnia Korani: I have been accepted into the JCO Trainee Reviewer Mentoring Program
Omnia Korani, Assistant Lecturer at the National Cancer Institute, shared a post on LinkedIn: "Exciting…
Jul 5, 2024, 13:47 | Insight
Andrea Apolo: Very proud of this Clinical Trial of Cabozantinib/Nivolumab published at JCO
Shilpa Gupta shared a post by Andrea Apolo, adding: "Huge congrats Andrea Apolo, leading this…
Jul 5, 2024, 06:54 | Blog
Paolo Tarantino: Nearly 1000 downloads in less than a week for our ATEMPT 5-year publication
Paolo Tarantino, posted on X: "Nearly 1000 downloads in less than a week for our…
Jul 4, 2024, 03:53 | Blog
Sarah Waliany: Reviewing the TRUST-1 trial investigating taletrectinib
Sarah Waliany, Thoracic Oncology Fellow at Mass General Cancer Center, shared the following post by…
Jul 3, 2024, 23:57 | Blog
Ajay Major: The newly-developed NLPHL prognostic score
Ajay Major, Assistant Professor at the University of Colorado School of Medicine and Founder and President…
Jul 3, 2024, 14:37 | Insight
Jarushka Naidoo: Phase III RESILIENT Trial of Liposomal Irinotecan v Topotecan in 2L SCLC
Jarushka Naidoo shared a post on X: “Phase III RESILIENT Trial of Liposomal Irinotecan v…
Jul 2, 2024, 10:32 | Insight
Trastuzumab emtansine (T-DM1) is highly effective in preventing stage 1 HER2-positive breast cancer from recurring - MedEdge MEA
MedEdge MEA shared a post on LinkedIn:  . "A year of treatment with a medicine…
Jul 2, 2024, 09:15 | Blog
Implementation of ChildGICR education programme on Cancer Registry Development - IARC
IARC shared a post on LinkedIn: “Researchers from International Agency for Research on Cancer (IARC) and…
Jul 1, 2024, 15:23 | Insight
Paolo Tarantino: Final analysis of the ATEMPT phase 2 trial
Paolo Tarantino shared a post on X: “Can ADCs help prevent recurrence from breast cancer…
Jun 29, 2024, 06:38 | Blog
Ajay Major: Methylphenidate versus piperonyl butoxide RCT for cancer related fatigue
Ajay Major, Assistant Professor at the University of Colorado School of Medicine and Founder and…
Jun 29, 2024, 05:30 | Insight
Zainab Shinkafi-Bagudu: Renewed Commitments to Eliminate Cervical Cancer
Zainab Shinkafi-Bagudu shared a post on X:           . "Following the first…
Jun 29, 2024, 05:21 | Insight
Piotr Wysocki: Adjuvant endocrine treatment in single and unemployed young breast cancer patients
Piotr Wysocki recently posted on LinkedIn: "The study by Julie A. Schmidt et al. published online in…
Jun 28, 2024, 13:17 | Blog
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
Zainab Shinkafi-Bagudu shared a post on LinkedIn:               . "Following…
Jun 25, 2024, 16:01 | Insight
Paolo Tarantino: Phase 1 trial of the HER2 topo1 ADC SHR-A1811 out in Journal of Clinical Oncology
Paolo Tarantino shared on X:  . "Phase 1 trial of the HER2 topo1 ADC SHR-A1811…
Jun 25, 2024, 14:07 | Insight
Piotr Wysocki: Minimally invasive surgery is out of the question in cervical cancer
Piotr Wysocki recently posted on LinkedIn: "Pedro Ramirez et al. published the results of the phase…
Jun 23, 2024, 19:16 | Insight
Joshua Richter: Amazing Paper on Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma
Joshua Richter, Associate Professor of Medicine, Hematology, and Medical Oncology at The Tisch Cancer Institute,…
Jun 22, 2024, 12:45 | Blog
José Sandoval: Socioeconomic inequalities in quality of life for patients with early breast cancer
José Sandoval, Clinical and Research Fellow at Curie Institute, shared on X: "Very happy that our…
Jun 22, 2024, 00:42 | Blog
Results from AMEERA-5 published in Journal of Clinical Oncology
Paolo Tarantino shared a post on X: "Results from AMEERA-5 published in Journal of Clinical Oncology.…
Jun 21, 2024, 14:36 | Insight
High ORR and low CRS rate with Linvoseltamab for R/R Multiple Myeloma
Recently Jeffrey Zonder shared a post on X about a recent paper by Naresh Bumma…
Jun 21, 2024, 02:08 | Insight
New Paper Alert! AtezoTRIBE Study
AtezoTRIBE Study: Adding Atezolizumab to FOLFOXIRI/Bevacizumab Improves Survival in Metastatic Colorectal Cancer, Especially in Biomarker-Selected…
Jun 20, 2024, 07:36 | Blog
LGBTQ+ patients report on their cancer care journey
Estela Rodriguez shared a post on X: "Disparities uncovered: LGBTQ+ patients report on their cancer care…
Jun 19, 2024, 14:22 | Insight
Zhi Ven Fong: Our study as June’s Feature article in Annals of Surgery
Zhi Ven Fong, Pancreas and Liver surgeon at Mayo Clinic, shared on X:  “Grateful to…
Jun 16, 2024, 19:29 | Insight
Preliminary Insights From the Global ONCOTRUST-1 Cross-Sectional Study
Kristina Jenei, Associate Editor at the Journal of Cancer Policy, shared on X/Twitter: "New original…
Jun 16, 2024, 01:22 | Insight
Ruzanna Papyan: Week 4 of the Global Access To Anti-GD2 Campaign
Ruzanna Papyan shared on LinkedIn: "Week 4 of the Global Access To Anti-GD2 Campaign This week,…
Jun 14, 2024, 14:08 | Blog
Rami Manochakian: Results of PALOMA3 study by Natasha B. Leighl et al
Rami Manochakian shared a post on X: "Hot off the press. Just published in Journal of…
Jun 13, 2024, 15:48 | Insight
Stephen Liu on a paper by Natasha Leighl, et al.
Stephen Liu recently shared a post on X: "PALOMA-3 results at Journal of Clinical Oncology…
Jun 13, 2024, 15:19 | Blog
Recent news from Journal of Clinical Oncology about HR+/HER2-negative breast cancer - ASCO
ASCO (American Society of Clinical Oncology) shared a post on X/Twitter: ''Recent news from Journal…
Jun 12, 2024, 08:00 | Insight
Erman Akkus on a paper by Ruben Malmberg, et al.
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: "Oral antihistamine…
Jun 10, 2024, 21:43 | Blog
Ramy Sedhom: So glad to see this piece making waves again on Twitter
Ramy Sedhom shared a post by Rebecca Shatsky on X, adding the following: “So glad…
Jun 10, 2024, 15:00 | Blog
Sumanta K. Pal: PIVOT09 comparing pegylated IL2/nivolumab to TKI by Nizar Tannir et al.
Sumanta K. Pal shared a post on X: “Huge congrats to Nizar Tannir, MD Anderson Cancer…
Jun 10, 2024, 11:09 | Insight
Phase II BLOSSOM Trial Osimertinib in LMD from EGFR+ NSCLC by Sehhoon Park et al.
Jarushka Naidoo shared a post on X: "Phase II BLOSSOM Trial Osimertinib in LMD (leptomeningeal…
Jun 10, 2024, 01:42 | Insight
Rebecca Shatsky: The Case for Focused Palliative Care Education in Oncology Training
Rebecca Shatsky shared on X/Twitter: "The Case for Focused Palliative Care Education in Oncology Training |…
Jun 9, 2024, 08:43 | Insight
Daniel Stover: Activity post-breast cancer diagnosis: Is ‘exercise’ just ‘exercise’?
Daniel Stover, Medical Oncologist and Computational Biologist at Ohio State University Comprehensive Cancer Center, shared…
Jun 9, 2024, 06:07 | Blog
Thomas J. Ettrich: Final results of our NIFE trial now published in 'Journal of Clinical Oncology'
Thomas J. Ettrich, Senior Physician, Department of Internal Medicine, University of Ulm, shared a post on…
Jun 8, 2024, 07:23 | Opinion
Benjamin Toll: Interesting study about nausea prevention with olanzapine
Benjamin Toll, Associate Director of Education at MUSC Hollings Cancer Center, shared a post on…
Jun 4, 2024, 02:42 | Insight
Stanley Ozogbo: Excited to share another abstract publication in the Journal of Clinical Oncology
Stanley Ozogbo, Resident Physician at Mercy Health, shared on X: "Excited to share another abstract publication…
May 30, 2024, 11:10 | Blog
Fumiko Ladd Chino: It's the 2nd annual Yellow Dress Challenge for ASCO24
Fumiko Ladd Chino shared on X/Twitter: "I'm calling an ASCO Fashion audible for those still packing…
May 29, 2024, 15:32 | Insight
Myeloma Paper of the Day, May 29th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Report of a modified Staging…
May 24, 2024, 14:53 | Insight
Timothée Olivier: Our analysis tion about adjuvant use of CDK4/6 inhibitors in early breast cancer
Vinay Prasad, Professor of Epidemiology and Biostatistics at the University of California, San Francisco, shared a…
May 22, 2024, 15:11 | Insight
Kimryn Rathmell: My editorial with Dr. Catherine Fahey highlighting a recent study by Dr. Joseph Unger
Kimryn Rathmell shared on X/Twitter: "A recent study by Dr. Joseph Unger, Fred Hutchinson Cancer Center +…
12
All: 173 Posts: 1 - 100
Special Coverage